193139-41-2 (Cyclolinopeptide B,CYCLOLINOPEPTIDE B)

免疫抑制活性多肽CYCLOLINOPEPTIDE B;

Cyclolinopeptide B;Cyclo(L-isoleucyl-L-methionyl-L-leucyl-L-isoleucyl-L-prolyl-L-prolyl-L-phenylalanyl-L-phenylalanyl-L-valyl);CYCLO(-PRO-PRO-PHE-PHE-VAL-ILE-MET-LEU-ILE);CID 131698083;PubChem ID: 10581956;Cyclolinopeptide B Cyclo(-Pro-Pro-Phe-Phe-Val-Ile-Met-Leu-Ile);CID 85194464;193139-41-2;24,27-Dibenzyl-9,18-di(butan-2-yl)-12-(2-methylpropyl)-15-(2-methylsulfanylethyl)-21-propan-2-yl-1,7,10,13,16,19,22,25,28-nonazatricyclo[28.3.0.03,7]tritriacontane-2,8,11,14,17,20,23,26,29-nonone;AKOS040735460;

MFCD01321204

BRDMGDLQYNAXNM-LNRPDFAYSA-N

1S/C56H83N9O9S/c1-10-35(7)46-54(72)57-39(26-29-75-9)48(66)58-40(30-33(3)4)50(68)63-47(36(8)11-2)56(74)65-28-19-25-44(65)55(73)64-27-18-24-43(64)52(70)60-41(31-37-20-14-12-15-21-37)49(67)59-42(32-38-22-16-13-17-23-38)51(69)61-45(34(5)6)53(71)62-46/h12-17,20-23,33-36,39-47H,10-11,18-19,24-32H2,1-9H3,(H,57,72)(H,58,66)(H,59,67)(H,60,70)(H,61,69)(H,62,71)(H,63,68)/t35-,36-,39+,40+,41+,42+,43+,44+,45+,46+,47+/m1/s1

S(C)CC[C@H]1C(N[C@@H](CC(C)C)C(N[C@@H]([C@H](C)CC)C(N2CCC[C@H]2C(N2CCC[C@H]2C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N1)=O)[C@H](C)CC)=O)C(C)C)=O)CC1C=CC=CC=1)=O)CC1C=CC=CC=1)=O)=O)=O)=O)=O